The interaction between HLA-G and ILT4 resulted in upregulation of vascular endothelial growth factor-C (VEGF-C) and B7-H3 expression in NSCLC patients via the ERK and PI3K/AKT/mTOR signaling pathways [82,83]. The gene discussed is VEGFC; the disease is non-small cell lung carcinoma.